The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global The Anti-infective Drugs for Animals market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in The Anti-infective Drugs for Animals market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China The Anti-infective Drugs for Animals production is XX (K Units). US market value in 2021 is about USD XX billion, and US The Anti-infective Drugs for Animals production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe The Anti-infective Drugs for Animals production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of The Anti-infective Drugs for Animals Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in The Anti-infective Drugs for Animals Market?
Bayer
Phibro Animal Health Corporation
Elanco
Boehringer Ingelheim
Merck
Ceva Santé Animale
Vetoquinol SA
Zoetis Inc.
AG Supply
Major Type of The Anti-infective Drugs for Animals Covered in XYZResearch report:
Antibacterial
Antivirals
Antifungals
Others
Application Segments Covered in XYZResearch Market
Cattle
Cats
Dogs
Other Animals
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global The Anti-infective Drugs for Animals Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global The Anti-infective Drugs for Animals Market by Value
2.2.1 Global The Anti-infective Drugs for Animals Revenue by Type
2.2.2 Global The Anti-infective Drugs for Animals Market by Value (%)
2.3 Global The Anti-infective Drugs for Animals Market by Production
2.3.1 Global The Anti-infective Drugs for Animals Production by Type
2.3.2 Global The Anti-infective Drugs for Animals Market by Production (%)
3. The Major Driver of The Anti-infective Drugs for Animals Industry
3.1 Historical & Forecast Global The Anti-infective Drugs for Animals Demand
3.2 Largest Application for The Anti-infective Drugs for Animals (2017-2027)
3.3 The Major Downstream Company in China Market 2021
4. Global and Regional The Anti-infective Drugs for Animals Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of The Anti-infective Drugs for Animals Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US The Anti-infective Drugs for Animals Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe The Anti-infective Drugs for Animals Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China The Anti-infective Drugs for Animals Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan The Anti-infective Drugs for Animals Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India The Anti-infective Drugs for Animals Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea The Anti-infective Drugs for Animals Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia The Anti-infective Drugs for Animals Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global The Anti-infective Drugs for Animals Average Price Trend
12.1 Market Price for Each Type of The Anti-infective Drugs for Animals in US (2017-2021)
12.2 Market Price for Each Type of The Anti-infective Drugs for Animals in Europe (2017-2021)
12.3 Market Price for Each Type of The Anti-infective Drugs for Animals in China (2017-2021)
12.4 Market Price for Each Type of The Anti-infective Drugs for Animals in Japan (2017-2021)
12.5 Market Price for Each Type of The Anti-infective Drugs for Animals in India (2017-2021)
12.6 Market Price for Each Type of The Anti-infective Drugs for Animals in Korea (2017-2021)
12.7 Market Price for Each Type of The Anti-infective Drugs for Animals in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
13.1 The Anti-infective Drugs for Animals Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of The Anti-infective Drugs for Animals
14. The Anti-infective Drugs for Animals Competitive Landscape
14.1 Bayer
14.1.1 Bayer Company Profiles
14.1.2 Bayer Product Introduction
14.1.3 Bayer The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Phibro Animal Health Corporation
14.2.1 Phibro Animal Health Corporation Company Profiles
14.2.2 Phibro Animal Health Corporation Product Introduction
14.2.3 Phibro Animal Health Corporation The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Elanco
14.3.1 Elanco Company Profiles
14.3.2 Elanco Product Introduction
14.3.3 Elanco The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Boehringer Ingelheim
14.4.1 Boehringer Ingelheim Company Profiles
14.4.2 Boehringer Ingelheim Product Introduction
14.4.3 Boehringer Ingelheim The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Merck
14.5.1 Merck Company Profiles
14.5.2 Merck Product Introduction
14.5.3 Merck The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Ceva Santé Animale
14.6.1 Ceva Santé Animale Company Profiles
14.6.2 Ceva Santé Animale Product Introduction
14.6.3 Ceva Santé Animale The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Vetoquinol SA
14.7.1 Vetoquinol SA Company Profiles
14.7.2 Vetoquinol SA Product Introduction
14.7.3 Vetoquinol SA The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Zoetis Inc.
14.8.1 Zoetis Inc. Company Profiles
14.8.2 Zoetis Inc. Product Introduction
14.8.3 Zoetis Inc. The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 AG Supply
14.9.1 AG Supply Company Profiles
14.9.2 AG Supply Product Introduction
14.9.3 AG Supply The Anti-infective Drugs for Animals Sales, Revenue (2017-2021)
Summary: Get latest Market Research Reports on Anti-infective Drugs for Animals. Industry analysis & Market Report on Anti-infective Drugs for Animals is a syndicated market report, published as (Post-pandemic Era)-Global The Anti-infective Drugs for Animals Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Anti-infective Drugs for Animals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.